NSC61610
Code | Size | Price |
---|
TAR-T28207-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28207-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
NSC61610 is a LANCL2 ligand with anti-inflammatory activity.
CAS:
500538-94-3
Formula:
C34H24N6O2
Molecular Weight:
548.606
Purity:
0.98
SMILES:
O=C(Nc1cccc(c1)-c1nc2ccccc2[nH]1)c1ccc(cc1)C(=O)Nc1cccc(c1)-c1nc2ccccc2[nH]1
References
1. Zhang Q, He Q, Xue F, Ma J. Inhibitor screening of lactate dehydrogenase C4 from black-lipped pika in the Western Sichuan Plateau. Biosci Biotechnol Biochem. 2014;78(4):651-4. doi: 10.1080/09168451.2014.890038. PubMed PMID: 25036963.
2. Lu P, Hontecillas R, Philipson CW, Bassaganya-Riera J. Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes. Curr Drug Targets. 2014 Jun;15(6):565-72. Review. PubMed PMID: 24628287.
3. Lu P, Hontecillas R, Horne WT, Carbo A, Viladomiu M, Pedragosa M, Bevan DR, Lewis SN, Bassaganya-Riera J. Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2. PLoS One. 2012;7(4):e34643. doi: 10.1371/journal.pone.0034643. PubMed PMID: 22509338; PubMed Central PMCID: PMC3324509.